Success Metrics

Clinical Success Rate

100.0%

Based on 1 completed trials

Completion Rate

100%(1/1)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Phase Distribution

Ph phase_2

33%

Ph not_applicable

33%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution2 total trials

Phase 2Efficacy & side effects

1(50.0%)

N/ANon-phased studies

1(50.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(1)

Terminated(1)

Other(1)

Detailed Status

unknown1

Withdrawn1

Completed1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 2

Trials by Phase

Phase 21 (50.0%)

N/A1 (50.0%)

Trials by Status

unknown133%

withdrawn133%

completed133%

Recent Activity

0 active trials

Showing 3 of 3

withdrawn

Malignant Ascites Alfapump® Study

NCT04076566

completednot_applicable

A (M)Ulti-center, Prospective, (O)Pen Label, Uncontrolled Feasibility (S)Tudy to Assess the Safety and Effectiveness of an Automatic Low Flow (A)Scites (Alfa) Pump (I)n Patients With (C)Irrhosis and Refractory or Recurrent Ascites

NCT02400164

unknownphase_2

Effects of Treatment of Ascites by the ALFApump System on Renal and Circulatory Function

NCT01438970

Clinical Trials (3)

Showing 3 of 3 trials

NCT04076566

Malignant Ascites Alfapump® Study

Withdrawn

NCT02400164Not Applicable

A (M)Ulti-center, Prospective, (O)Pen Label, Uncontrolled Feasibility (S)Tudy to Assess the Safety and Effectiveness of an Automatic Low Flow (A)Scites (Alfa) Pump (I)n Patients With (C)Irrhosis and Refractory or Recurrent Ascites

Completed

NCT01438970Phase 2

Effects of Treatment of Ascites by the ALFApump System on Renal and Circulatory Function

Unknown

All 3 trials loaded

Drug Details

Intervention Type: DEVICE
Total Trials: 3